BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Adipose tissue, Laryngoscope, Lovastatin, rs2230926, TGFB1, T cell differentiation)
Bookmark Forward

QuickView for central nervous system vasculogenesis (biogroup)


Body Atlas

Most Correlated Tissues

  1. Tongue superior part with papillae
  2. Breast tissue
  3. Fallopian tube
  4. Trigeminal ganglia
  5. Prostate gland
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Stachybotryotoxicosis
  2. Osler hemorrhagic telangiectasia syndrome
  3. Toxic effect of mycotoxin
  4. Alpha-1-antitrypsin deficiency
  5. Poisoning by drug AND/OR medicinal substance
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. NMS-873
  2. Allergens
  3. H 1152
  4. RPI-1 cpd
  5. Chemokine CCL17
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. Map3k1
  2. MBD3
  3. VCP
  4. PAK1
  5. LACTB
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. Wnt-Bmp signaling dynamics in tooth organogenesis
  2. Liver progenitor cell lines derived from mice with liver injury
  3. Cbx4 mutants in the chromodomain and sumoylation site affects in keratinocytes
  4. Whole blood samples from healthy donors stimulated in vitro with Pam3CSK4 or LPS
  5. Chorioamniotic membranes from women at term in labor, not in labor and in premature labor
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Morphometric analysis on the effects of hypoxia during the central nervous system vasculogenesis.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic…
  2. Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, …
  3. AGA Biocellular Stem/Stromal Hair Regenerative Study
  4. Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata
  5. A Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, in Patients With Advanced Solid Tumors
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.